Acadia Healthcare (NASDAQ:ACHC) Upgraded by Deutsche Bank Aktiengesellschaft to Buy Rating

Deutsche Bank Aktiengesellschaft upgraded shares of Acadia Healthcare (NASDAQ:ACHC) from a hold rating to a buy rating in a research report report published on Thursday, Marketbeat Ratings reports. They currently have $75.00 price objective on the stock, up from their previous price objective of $45.00.

ACHC has been the subject of a number of other reports. StockNews.com lowered shares of Acadia Healthcare from a “hold” rating to a “sell” rating in a report on Friday, November 22nd. Barclays dropped their price objective on Acadia Healthcare from $76.00 to $43.00 and set an “overweight” rating for the company in a research note on Friday, November 22nd. KeyCorp assumed coverage on shares of Acadia Healthcare in a report on Friday, October 11th. They set a “sector weight” rating for the company. Royal Bank of Canada dropped their price objective on shares of Acadia Healthcare from $94.00 to $64.00 and set an “outperform” rating for the company in a report on Monday, November 18th. Finally, Cantor Fitzgerald reaffirmed a “neutral” rating and issued a $52.00 price objective on shares of Acadia Healthcare in a research note on Tuesday. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and seven have issued a buy rating to the stock. According to MarketBeat, Acadia Healthcare currently has an average rating of “Moderate Buy” and an average target price of $75.44.

Acadia Healthcare Stock Performance

Shares of ACHC opened at $40.34 on Thursday. The firm has a market capitalization of $3.75 billion, a P/E ratio of 13.23, a PEG ratio of 1.82 and a beta of 1.29. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.07 and a quick ratio of 1.07. The business has a fifty day moving average of $45.69 and a 200 day moving average of $61.98. Acadia Healthcare has a one year low of $36.50 and a one year high of $87.77.

Acadia Healthcare (NASDAQ:ACHC) last announced its earnings results on Wednesday, October 30th. The company reported $0.91 EPS for the quarter, beating analysts’ consensus estimates of $0.90 by $0.01. The business had revenue of $815.60 million during the quarter, compared to analysts’ expectations of $819.42 million. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.12%. The firm’s revenue was up 8.7% on a year-over-year basis. During the same period in the prior year, the company earned $0.91 earnings per share. As a group, sell-side analysts anticipate that Acadia Healthcare will post 3.38 EPS for the current year.

Hedge Funds Weigh In On Acadia Healthcare

A number of large investors have recently bought and sold shares of ACHC. Blue Trust Inc. boosted its stake in shares of Acadia Healthcare by 86.1% during the second quarter. Blue Trust Inc. now owns 536 shares of the company’s stock valued at $36,000 after purchasing an additional 248 shares during the period. GAMMA Investing LLC raised its stake in shares of Acadia Healthcare by 57.1% during the third quarter. GAMMA Investing LLC now owns 663 shares of the company’s stock valued at $42,000 after acquiring an additional 241 shares in the last quarter. Point72 Asia Singapore Pte. Ltd. bought a new position in Acadia Healthcare in the second quarter worth approximately $59,000. Covestor Ltd raised its position in Acadia Healthcare by 834.4% during the 3rd quarter. Covestor Ltd now owns 1,140 shares of the company’s stock valued at $72,000 after purchasing an additional 1,018 shares in the last quarter. Finally, DekaBank Deutsche Girozentrale purchased a new stake in shares of Acadia Healthcare in the 3rd quarter worth $86,000.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.